Stefanos Theoharis, new CEO of OneChain Immunotherapeutics Blog Post

OneChain Immunotherapeutics (OCI), a clinical-stage biotechnology company focused on the development of CAR T therapies for the treatment of oncologic diseases, announced Stefanos Theoharis as the company’s new Chief Executive…